Solutions

Our Solutions

CRO

Molecular diversity, including various heterocyclic compounds containing N, O, S, and combinations.

Modified carbohydrates and nucleosides

Small modified peptides

API for tox and pre-clinical

GMP API for clinical phase

Al for clinical studies (Phases I, II, III)

Digitised discovery platforms

CDMO

Integrated technology transfer, development capabilities, and engineering teams

Kilo lab - Multiple MOCs, ranging from 51 to 100L

Pilot plant - 100L to 500L

Commercial manufacturing - 100L to 8KL

Validated QMS enabled at multiple geographical locations - EU, India, US

KSM & API

Large-scale automated KSM manufacturing set-up capable of handling hazardous reactions involving fluorination, bromination, phosgenation, etc.

Fully digitised set-up capable of manufacturing small and large molecules

24 active DMFs in 39 countries

200 active customers

Supplying to more than 50 countries worldwide.

Full life cycle knowledge from KSM to API

Our Enablers

Why Us

Established KSM supplier on a large scale for a variety of products for various companies, including toxic materials.

Dedicated cGMP blocks can be allocated to any customer with high volumes and price proposition through manufacturing capabilities in India and Italy

Single ownership and end-to-end delivery: R&D for development in Jaipur, Hyderabad, Lodi, and Alabama ➔ KSM manufacturing in Jaipur ➔ GMP manufacturing in Lodi

Our R&D center in the US facilitates rapid compound synthesis due to

1. in-country sourcing of chemicals for comprehensive route scouting

2. 24/7 coordination with US-based customers

In-house KSM manufacturing at PIHSL offers

(i) cost-efficiency and

(ii) a seamless transfer of developed processes to a cGMP facility by our own professionals, thereby reducing time in technology transfer

We take a proactive approach to ‘Dual Sourcing’ of Fine Chemicals (due to changing geopolitical situations) through outsourcing and developing in-house processes and manufacturing in dedicated facilities.

Globally, we rank among the Top Decile companies in ESG

Flow Chemistry and CSTR (Continuous Stirred Tank Reactor) capabilities (lab and pilot scales)

Financial stability – Our parent company, PI Industries, has a market cap exceeding US$6 billion and is a debt-free company. This financial strength allows us to invest in the desired capabilities and capacities to continuously meet customer requirements

PI has a history of launching successful businesses ranging from Agchem brands, Contract Manufacturing, Mining, Polymers, Energy and now Pharma.